1. Home
  2. MDXH vs FNGR Comparison

MDXH vs FNGR Comparison

Compare MDXH & FNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • FNGR
  • Stock Information
  • Founded
  • MDXH 2003
  • FNGR 2016
  • Country
  • MDXH Belgium
  • FNGR Singapore
  • Employees
  • MDXH N/A
  • FNGR N/A
  • Industry
  • MDXH
  • FNGR Computer Software: Prepackaged Software
  • Sector
  • MDXH
  • FNGR Technology
  • Exchange
  • MDXH Nasdaq
  • FNGR Nasdaq
  • Market Cap
  • MDXH 73.3M
  • FNGR 72.0M
  • IPO Year
  • MDXH 2021
  • FNGR N/A
  • Fundamental
  • Price
  • MDXH $1.76
  • FNGR $1.86
  • Analyst Decision
  • MDXH Buy
  • FNGR
  • Analyst Count
  • MDXH 1
  • FNGR 0
  • Target Price
  • MDXH $6.00
  • FNGR N/A
  • AVG Volume (30 Days)
  • MDXH 55.7K
  • FNGR 235.1K
  • Earning Date
  • MDXH 05-05-2025
  • FNGR 05-28-2025
  • Dividend Yield
  • MDXH N/A
  • FNGR N/A
  • EPS Growth
  • MDXH N/A
  • FNGR N/A
  • EPS
  • MDXH N/A
  • FNGR N/A
  • Revenue
  • MDXH $90,049,000.00
  • FNGR $33,570,107.00
  • Revenue This Year
  • MDXH $23.38
  • FNGR $260.03
  • Revenue Next Year
  • MDXH $16.84
  • FNGR N/A
  • P/E Ratio
  • MDXH N/A
  • FNGR N/A
  • Revenue Growth
  • MDXH 28.29
  • FNGR N/A
  • 52 Week Low
  • MDXH $1.35
  • FNGR $1.03
  • 52 Week High
  • MDXH $3.50
  • FNGR $3.96
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 66.56
  • FNGR 70.21
  • Support Level
  • MDXH $1.51
  • FNGR $1.25
  • Resistance Level
  • MDXH $1.64
  • FNGR $1.53
  • Average True Range (ATR)
  • MDXH 0.08
  • FNGR 0.14
  • MACD
  • MDXH 0.04
  • FNGR 0.05
  • Stochastic Oscillator
  • MDXH 93.02
  • FNGR 85.47

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

About FNGR FingerMotion Inc.

FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.

Share on Social Networks: